Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Nat Med. 2013 May;19(5):646-51. doi: 10.1038/nm.3154. Epub 2013 Apr 14.
Approximately 100,000 individuals in the United States currently await kidney transplantation, and 400,000 individuals live with end-stage kidney disease requiring hemodialysis. The creation of a transplantable graft to permanently replace kidney function would address donor organ shortage and the morbidity associated with immunosuppression. Such a bioengineered graft must have the kidney's architecture and function and permit perfusion, filtration, secretion, absorption and drainage of urine. We decellularized rat, porcine and human kidneys by detergent perfusion, yielding acellular scaffolds with vascular, cortical and medullary architecture, a collecting system and ureters. To regenerate functional tissue, we seeded rat kidney scaffolds with epithelial and endothelial cells and perfused these cell-seeded constructs in a whole-organ bioreactor. The resulting grafts produced rudimentary urine in vitro when perfused through their intrinsic vascular bed. When transplanted in an orthotopic position in rat, the grafts were perfused by the recipient's circulation and produced urine through the ureteral conduit in vivo.
目前,美国约有 10 万人等待肾脏移植,40 万人患有终末期肾病需要接受血液透析。创造可移植的移植物以永久替代肾功能将解决供体器官短缺和免疫抑制相关的发病率问题。这种生物工程化的移植物必须具有肾脏的结构和功能,并允许灌注、过滤、分泌、吸收和排出尿液。我们通过去污剂灌注使大鼠、猪和人肾脏去细胞化,得到具有血管、皮质和髓质结构、收集系统和输尿管的无细胞支架。为了再生功能性组织,我们将大鼠肾脏支架接种上皮细胞和内皮细胞,并在全器官生物反应器中对这些细胞接种的构建体进行灌注。当通过其固有血管床进行灌注时,所得移植物在体外产生基本尿液。当在大鼠的原位移植时,移植物被受者的循环灌注,并通过输尿管导管在体内产生尿液。